Background Intravenous immune globulin (IVIG) for the treatment of dermatomyositis has not
been extensively evaluated. Methods We conducted a randomized, placebo-controlled trial …

The enhancement of immune responses upon treatment with immune checkpoint inhibitors
can have the desired outcome of reinvigorating antitumour immune surveillance, but often at …

Objective. Knowledge about the range of symptoms experienced by patients with SSc, and
their impact on daily functioning is limited. The objective of the present study was to identify …

Objective To assess the risk of acute myocardial infarction (AMI) associated with the use of
disease‐modifying antirheumatic drugs (DMARDs) and other medications commonly used in …

The vision of Chandler (Chan) S. Robbins for a continental-scale omnibus survey of breeding
birds led to the development of the North American Breeding Bird Survey (BBS). Chan was …

BackgroundItem 9 of the Patient Health Questionnaire-9 (PHQ-9) queries about thoughts of
death and self-harm, but not suicidality. Although it is sometimes used to assess suicide risk, …

Immunoglobulin E (IgE) is a central mediator of allergic (atopic) inflammation. Therapies
directed against IgE can alleviate hay fever 1 and allergic asthma 1 , 2 . Genetic association …

In this study, 1,833 systemic sclerosis (SSc) cases and 3,466 controls were genotyped with
the Immunochip array. Classical alleles, amino acid residues, and SNPs across the human …

Objective Spontaneous reports of interstitial lung disease (ILD) in patients with rheumatoid
arthritis (RA) treated with leflunomide, a disease‐modifying antirheumatic drug (DMARD), …

Objective A number of studies (all n <200) have assessed health‐related quality of life (HRQOL)
in patients with systemic sclerosis (SSc), but no systematic review of the effect of SSc on …